Sign in

    Stephen Wagner

    Managing Director and Senior Equity Research Analyst at Jefferies

    Stephen Wagner is a Managing Director and Senior Equity Research Analyst at Jefferies, specializing in the healthcare and medical devices sector. He covers companies such as Abbott Laboratories, Boston Scientific, Becton Dickinson, and Medtronic, with an established track record for accurate stock recommendations and strong performance metrics, including consistent top-tier rankings and above-market returns on key calls. Wagner began his career in equity research in the early 2000s, previously working at institutions such as UBS and Bank of America Merrill Lynch before joining Jefferies in 2014. He holds FINRA Series 7, 63, 86, and 87 securities licenses, and is recognized for his in-depth industry knowledge and rigorous analytical approach.

    Stephen Wagner's questions to Sally Beauty Holdings (SBH) leadership

    Stephen Wagner's questions to Sally Beauty Holdings (SBH) leadership • Q2 2025

    Question

    Stephen Wagner asked which product innovations are currently driving the most traffic and conversion in stores.

    Answer

    President and CEO Denise Paulonis highlighted that on the professional BSG side, the trend toward a smooth, 'glass hair' look is driving traction, supported by new launches from K18, Moroccan oil, and Amica. On the consumer-facing Sally side, she pointed to notable strength in press-on nails and a pickup in the company's own hair color brands. She noted the company is well-positioned with both owned and partner brands like Wella to support these key trends.

    Ask Fintool Equity Research AI